Physicians who meet with patients via direct to consumer telemedicine services are just as likely to prescribe antibiotics as those who conduct in-person visits, according to a study conducted by Rand ...

Last week, JAMA Internal Medicine published a two-page research letter by the Rand Corporation that played into a national conversation about the efficacy of telemedicine -- specifically Teladoc, a ...

Telemedicine allows for many advantages with virtual doctor's appointments and remote access to care. Here's how it can ...

However, Teladoc has not performed well since it reached its all-time high in early 2021, and since then, the stock is down ...

Teladoc's depressed valuation reflects justified skepticism, with lackluster growth, declining premium engagement, and mounting competitive threats from insurers and tech giants. Financial metrics ...

As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the online marketplace industry, including Teladoc (NYSE:TDOC) and its peers.

Like all companies, Teladoc Health (NYSE: TDOC) will need to evolve a lot over the next three years. The days of the telehealth operator's peak hype are now firmly in the past. It's up to management ...

Teladoc reports second-quarter revenue of $631.9 million, beating analyst estimates of $623.1 million. Teladoc reports a second-quarter loss of 19 cents per share, beating analyst estimates for a loss ...